These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 31881623)

  • 21. Nonendoscopic deactivation of nerve triggers in migraine headache patients: surgical technique and outcomes.
    Gfrerer L; Maman DY; Tessler O; Austen WG
    Plast Reconstr Surg; 2014 Oct; 134(4):771-778. PubMed ID: 24945947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical outcomes following supraorbital foraminotomy for treatment of frontal migraine headache.
    Chepla KJ; Oh E; Guyuron B
    Plast Reconstr Surg; 2012 Apr; 129(4):656e-662e. PubMed ID: 22456379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Migraine disability assessment (MIDAS) score: relation to headache frequency, pain intensity, and headache symptoms.
    Stewart WF; Lipton RB; Kolodner K
    Headache; 2003 Mar; 43(3):258-65. PubMed ID: 12603645
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patient Pain Sketches Can Predict Surgical Outcomes in Trigger-Site Deactivation Surgery for Headaches.
    Gfrerer L; Hansdorfer MA; Ortiz R; Nealon KP; Chartier C; Runyan GG; Zarfos SD; Austen WG
    Plast Reconstr Surg; 2020 Oct; 146(4):863-871. PubMed ID: 32970009
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of preoperative migraine headache frequency on surgical outcomes.
    Molavi S; Zwiebel S; Gittleman H; Alleyne B; Guyuron B
    Plast Reconstr Surg; 2014 Dec; 134(6):1306-1311. PubMed ID: 25415096
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A socioeconomic analysis of surgical treatment of migraine headaches.
    Faber C; Garcia RM; Davis J; Guyuron B
    Plast Reconstr Surg; 2012 Apr; 129(4):871-877. PubMed ID: 22183497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Effectiveness of Peripheral Nerve Blocks for Diagnosis of Migraine Trigger Points.
    Rangwani SM; Hehr JC; Janis JE
    Plast Reconstr Surg; 2021 Dec; 148(6):992e-1000e. PubMed ID: 34847126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surgical Management of Migraine Headache.
    Jose A; Nagori SA; Roychoudhury A
    J Craniofac Surg; 2018 Mar; 29(2):e106-e108. PubMed ID: 29068972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trigger areas nerve decompression for refractory chronic migraine.
    Chen G; You H; Juha H; Lou B; Zhong Y; Lian X; Peng Z; Xu T; Yuan L; Woralux P; Hugo AB; Jianliang C
    Clin Neurol Neurosurg; 2021 Jul; 206():106699. PubMed ID: 34053808
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Topiramate treatment of chronic migraine: a randomized, placebo-controlled trial of quality of life and other efficacy measures.
    Silberstein S; Lipton R; Dodick D; Freitag F; Mathew N; Brandes J; Bigal M; Ascher S; Morein J; Wright P; Greenberg S; Hulihan J
    Headache; 2009 Sep; 49(8):1153-62. PubMed ID: 19719543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Migraine headache trigger site prevalence analysis of 2590 sites in 1010 patients.
    Seyed Forootan NS; Lee M; Guyuron B
    J Plast Reconstr Aesthet Surg; 2017 Feb; 70(2):152-158. PubMed ID: 27931736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of preoperative narcotic use on outcomes in migraine surgery.
    Adenuga P; Brown M; Reed D; Guyuron B
    Plast Reconstr Surg; 2014 Jul; 134(1):113-119. PubMed ID: 24622571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Greater occipital nerve excision for occipital neuralgia refractory to nerve decompression.
    Ducic I; Felder JM; Khan N; Youn S
    Ann Plast Surg; 2014 Feb; 72(2):184-7. PubMed ID: 24322636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Current Means for Detection of Migraine Headache Trigger Sites.
    Guyuron B; Nahabet E; Khansa I; Reed D; Janis JE
    Plast Reconstr Surg; 2015 Oct; 136(4):860-867. PubMed ID: 26397259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of symptomatic pseudomeningocele on improvement in pain, disability, and quality of life following suboccipital decompression for adult Chiari malformation type I.
    Parker SL; Godil SS; Zuckerman SL; Mendenhall SK; Tulipan NB; McGirt MJ
    J Neurosurg; 2013 Nov; 119(5):1159-65. PubMed ID: 24010974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recognition and management of migraine in primary care: influence of functional impact measured by the headache impact test (HIT).
    De Diego EV; Lanteri-Minet M
    Cephalalgia; 2005 Mar; 25(3):184-90. PubMed ID: 15689193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Tools for assessing patient perception of the impact of migraine].
    El Hasnaoui A; Doble A; Gaudin AF
    CNS Drugs; 2006; 20 Spec no.1():24-36. PubMed ID: 16841524
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Positive and Negative Predictive Value of Targeted Diagnostic Botox Injection in Nerve Decompression Migraine Surgery.
    ElHawary H; Kavanagh K; Janis JE
    Plast Reconstr Surg; 2024 May; 153(5):1133-1140. PubMed ID: 37285182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Novel Surgical Approach to Chronic Temporal Headaches.
    Peled ZM
    Plast Reconstr Surg; 2016 May; 137(5):1597-1600. PubMed ID: 27119933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.